Skip to content
Home/Companies/Biotech/Vaccitech

Vaccitech

Biotech·UK·Exited 2021·Held 5yr
Entry
2016
Hold
5yr
Exit
2021

Who owns Vaccitech?

Vaccitech was owned by Oxford Science Enterprises through Oxford Science Enterprises Balance Sheet (2015 vintage) from 2016 to 2021, exited via IPO.

Hand-verified · updated 2026-06-11

Oxford Science Enterprises
Investor
Oxford Science Enterprises
Oxford Science Enterprises Balance Sheet · 2015 · Balance Sheet

Key facts

HQUK
SectorBiotech
StatusActive
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2021

More from Oxford Science Enterprises Balance Sheet

Other portfolio companies in the same fund.

Allos
Allos
Active
AI/MLUK· 2026
Caudal Energy
Active
EnergyUK· 2026
Densix
Active
Deep TechUK· 2026
Marley Health
Marley Health
Active
HealthTechUK· 2026
Stateful Robotics
Stateful Robotics
Active
Deep TechUK· 2026
Alethio Therapeutics
Active
BiotechUK· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Vaccitech

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Vaccitech.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue